Article Text

Download PDFPDF
Reminder of important clinical lesson
Essential thrombocythemia in a young man treated for myocardial infarction
  1. S Pande1,
  2. R Joshi2,
  3. R Pande3
  1. 1Department of Rehabilitation Medicine, Changi General Hospital, Singapore
  2. 2Department of Haematology, St Mary's Hospital, Isle of Wight, UK
  3. 3General Practice, Leigh, UK
  1. Correspondence to S Pande, shrikantpande{at}yahoo.co.uk

Summary

Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm which can cause thrombohaemorrhagic complications usually involving microvasculature.

Medium-sized arterial thrombosis has been reported, but coronary occlusion usually occurs with additional risk factors, for example, smoking, hyperlipidaemia and so on.

We present a case of acute myocardial infarction (AMI) in a young man (29 years) with ET but without any coronary artery associated risk factors. He was successfully treated for his AMI and ET with cytoreductive treatment and has recovered well.

Due to automated platelet counting, ET is being increasingly identified; early detection can prevent long-term complications, and patients can have normal life span.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests None.

  • Patient consent Obtained.